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The influences of ZnO nanoparticles on cellular responses to activation of 
muscarinic receptors were studied in Chinese hamster ovary cells expressing the human 
M3 muscarinic acetylcholine receptor. ZnO particles (20 nm) induced cytotoxicity in a 
time and concentration-dependent manner: following a 24 h exposure, toxicity was 
minimal at concentrations below 20 µg/ml but virtually complete at concentrations above 
28 µg/ml. ZnO particles did not affect antagonist binding to M3 receptors or allosteric 
ligand effects, but increased agonist binding affinity while eliminating guanine nucleotide 
sensitivity. At a noncytotoxic concentration (10 µg/ml), ZnO increased resting [Ca2+]i 
from 40 to 130 nM without compromising calcium homeostatic mechanisms. ZnO 
particles had minimal effects on inositol 1,4,5-trisphosphate (IP3)- or thapsigargin-
mediated release of intracellular calcium from the endoplasmic reticulum, but strongly 
inhibited store operated calcium entry (capacitive calcium entry). The latter effect was 
seen as 1) a decrease in the plateau phase of the response and 2) a decrease in Ca2+ entry 
upon introduction of calcium to the extracellular medium following thapsigargin-induced 
depletion of calcium from the endoplasmic reticulum (EC50’s  ≈ 2 µg/ml). Thus, ZnO 
nanoparticles interfere with two specific aspects of the M3 signaling pathway, agonist 
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1.1.  ZINC OXIDE NANOMATERIALS 
Nanomaterials (materials that have at least one dimension in the range of 1-100 
nm) are widely used in as the production of cosmetic products, transparent conductive 
paints and filters. Unintended exposure to nanomaterials may occur with occupational 
workers and end product users through inhalation, dermal absorption, or gastrointestinal 
tract absorption. The adverse effects of nanomaterials of various sizes and compositions 
on human health is being addressed (e.g., (Braydich-Stolle et al., 2005); (Gurr et al., 
2005); (Jeng and Swanson, 2006); (Lewinski et al., 2008); (Lin et al., 2006a); (Lin et al., 
2006b);(Lin et al., 2008); (Moller et al., 2005); (Timblin et al., 2002)). 
ZnO nanoparticles are used in catalysis, paints, wave filters, UV detectors, 
transparent conductive films, varistors, gas sensing monitors, solar cells, and sunscreens 
and other cosmetic products ((Bae, 2004); (Bai et al., 2003); (Comini et al., 2002); (Ding 
and Wang, 2004); (Huang et al., 2006); (Ramakrishna and HGhosh, 2003); (Zhu et al., 
2005)).  Inhalation of ZnO compromises pulmonary function in pigs and causes 
pulmonary impairment and metal fume fever in humans ((Beckett et al., 2005); (Fine et 
al., 1997)).   
The cytotoxicity of nano- and micro- size ZnO particles in cultured human 
bronchoaveolar carcinoma-derived cells (A549) (Lin et al., 2006a) and human bronchial 
epithelial cells (BEAS-2B) ((Huang et al., 2009); (Lin et al., 2008)) has recently been 
documented in the laboratory of Dr. Yue-Wern Huang at Missouri S & T. This toxicity is 
associated with elevated oxidative stress (OS), oxidative DNA damage, and the up-
regulation of several genes involved in oxidative stress responses and apoptosis. ZnO 
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toxicity is mitigated by treatment with the antioxidant N–acetylcysteine. ZnO exposure 
also causes an increase in resting intracellular calcium levels in human bronchial 
epithelial cells (Huang et al., 2009).  
Particles in both the nano- and micrometer range damage the olfactory bulb, 
disrupt the blood brain barrier, and gain entry to the central nervous system ((Calderon-
Garciduenas et al., 2002); (Calderon-Garciduenas et al., 2001); (Elder et al., 2006); 
(Sharma and Sharma, 2007); (Veronesi et al., 2005)). The purpose of this research was to 
determine the extent to which ZnO nanoparticles disrupt synaptic signaling processes in a 
model system, M3 muscarinic receptors, expressed in Chinese hamster ovary (CHO) 
cells. Ion channels and synaptic signaling macromolecules are particularly susceptible to 
toxicological agents, reflecting their exposed positions.  
 
 
1.2. MUSCARINIC RECEPTORS 
Acetylcholine (ACh), the first neurotransmitter to be identified, exerts its diverse 
physiological actions by binding to and activating two structurally and functionally 
distinct families of cell-surface receptors — the nicotinic ACh receptors (nAChRs) and 
the muscarinic ACh receptors (mAChRs). Muscarinic receptors are members of the 
superfamily of G-protein-coupled receptors (GPCRs). Molecular-cloning studies have 
revealed the existence of five molecularly distinct mammalian mAChR subtypes, M1–
M5. They are numbered in the order of their discovery, which also reflects their relative 
abundance. The M1–M5 receptors can be subdivided into two major functional classes 
according to their G-protein coupling preference. The M1, M3 and M5 receptors 
selectively couple to G-proteins of the Gq/G11 family, whereas the M2 and M4 receptors 
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preferentially activate Gi/Go‑type G-proteins1,2  (Figure 1.1). Agonist-induced 
activation of mAChRs leads to a wide range of biochemical and electrophysiological 
responses ((Wess, 1996); (Caulfield and Birdsall, 1998); (Nathanson, 2000 ); (Lanzafame 
et al., 2003) ; (Figure 1.1). The precise nature of these responses and the resulting 
physiological effects depend primarily on the location and the molecular identity of the 
activated mAChR subtype(s) ((Wess, 1996) ; (Caulfield and Birdsall, 1998); (Nathanson, 










1.2.1. Structure of Muscarinic Receptors.  The cDNAs for the muscarinic 
receptors encode glycoproteins of 55 to 70 kDa, which contain seven transmembrane-
spanning regions. Muscarinic receptors are comprised of a single polypeptide of 500-
540 amino acids that have an intracellular N-terminus and an intracellular C-terminus 




Figure 1.2. Possible arrangement of muscarinic receptor transmembrane domains, as 





Figure 1.3 indicate four consensus sites for glycosylation at asparagines (N) 
residues on the extracellular N-terminal domain. The aspartate (D), tyrosine (Y) and 
threonine (T) residues in the membrane-spanning regions that are involved in agonist 
binding are highlighted in yellow.  The region of the third intracellular loop involved in G 




Figure 1.3. Schematic diagram of a human M2 muscarinic receptor showing the primary 






1.2.2. Signal Transduction Mediated by Muscarinic Receptors.  Figure 1.4 
indicates that after receptors are activated by binding of an agonist, the β-γ subunit of G 
protein dissociates from the α-subunit. GDP is replaced by GTP. The GTP bound α-
subunit, as well as the β-γ subunit, can consequently act on effector molecules.  For M1, 
M3 and M5 mAChR’s, the effector is hospholipase C-β, which hydrolyzed 
Phosphatidylinositol 4,5-bisphosphate (PIP2) intop inositol 1,4,5-trisphosphate (IP3) and 
diacylglycerol (DAG) . IP3 is a “second messenger” in transducing the muscarinic signal; 
IP3 interacts with IP3 receptors in the endoplasmic reticulum (ER) membrane. IP3 
receptors encompass a channel that permit the rapid release of Ca2+ from the ER, giving  
rise to a fast initial increase in cytoplasmic Ca2+ concentration ([Ca2+]i ) (Patterson et al., 
2004). Following this release of Ca2+, a slower and more enduring entry of Ca2+ into the 
cytoplasm known an extracellular source occurs, providing persistent Ca2+ signals. Ca2+ 
depletion from the ER causes the Ca2+-sensing STIM1 protein in the ER menmbrane to 
aggregate in areas close to the plasma membrane and to interact with Orai1 in the plasma 
membrane. Orai1 is the store-operated channel (Venkatachalam et al., 2002)  
 
 
Figure 1.4. Receptor-mediated Ca2+ entry pathways. 
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2. MATERIALS AND METHODS 
2.1. MATERIALS 
[3H]N-Methylscopolamine (82 Ci/mmol) was obtained from Perkin Elmer 
(Boston, MA, U.S.A.). Cell lines were provided by Missouri S & T cDNA Resource 
Center. DME/F-12 1:1 media (Thermo, Utah, USA) was supplemented 10% fetal calf 
serum, 1mM L-glutamine, 1% (vol/vol) penicillin and streptomycin solution. All the 
chemicals were purchased from Sigma Chemical Co. (St. Louis, MO, USA). Phosphate-
buffered saline (PBS), trypsin and atropine were purchased from Fisher. Fura2-AM and 
F127 were purchased from invetrogen. Twenty nanometer ZnO particles at > 99% purity 
were purchased from Nanostructured and Amorphous Materials (Los Alamos, New 
Mexico, USA). 
 
2.2. CELL CULTURE AND CYTOTOXICITY MEASUREMENTS 
CHO cells stably transfected with a cDNA clone (in pcDNA3.1+; Invitrogen) of 
the human M3 muscarinic acetylcholine receptor open reading frame (cDNA Resource 
Center, www.cdna.org) were cultured in DME/F12 media containing 10% FCS and 
penicillin/streptomycin (100 IU/100 µg/ml) at 37° in a 5% CO2 humidified environment.  
Cell viability was determined using the MTS reduction assay (3-(4,5-dimethylthiazol-2-
yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium, inner salt; Promega, 
Madison). Approximately 8000 cells were seeded in to each well of a 96-well plate and 




2.3. MUSCARINIC RECEPTOR BINDING 
[3H]N-methylscopolamine ([3H]MS; PerkinElmer), a non-selective antagonist, 
was used to label muscarinic receptors. CHO-M3 cells were homogenized in 50 mM 
Tris-HCl (pH 7.4), and an aliquot (15-30 µg protein) was incubated in the presence of 
[3H]MS and 50 mM Tris-HCl (pH 7.4) for 60 minutes at room temperature in a final 
volume of 1 ml. In some experiments, the cells were exposed to ZnO nanoparticles for 5 
hours before harvesting. Binding was determined by filtration of the homogenized cells 
through glass fiber filters (1 µm pore size), followed by measurement of the radioactivity 
trapped on the filters by liquid scintillation counting. Non-specific binding was 
determined by including 10 µM unlabelled atropine in the incubation media.   [3H]MS 
binding parameters (receptor concentration, dissociation constant, dissociation rate 
constant) were determined by nonlinear regression (DeltaGraph) using a model 
incorporating a single population of independent binding sites. Parameters were averaged 
from 3-5 independent experiments. Agonist binding affinity was determined in 
competition studies using carbamylcholine and 0.3 nM [3H]MS. In some experiments, a 
guanine nucleotide (5’-guanylyl-imidodiphosphate; Gpp(NH)p) was included in the 
binding medium to assess receptor coupling to transducer G proteins. 
 
2.4. MEASUREMENT OF INTRACELLULAR CALCIUM 
The concentration of intracellular calcium ([Ca2+]i) was monitored using the 
calcium-sensitive fluorescent dye, fura-2 (Molecular Probes) in a ratio metric assay. Cells 
(250,000) were seeded onto 35 mm glass bottom dishes and incubated for 16 h. The cells 
were then incubated with fura-2AM for 1h at room temperature in phenol red free 
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DMEM media. The cells were washed with 2 ml fresh basal salt solution (BSS) 
comprised of 130 mM NaCl, 5.4 mM KCl, 5.5 mM glucose, 2 mM CaCl2, 1 mM MgCl2, 
and 20 mM HEPES, at pH 7.4., and the incubation continued for an additional 30 min. In 
“acute exposure” experiments, the ZnO nanoparticles were added at this point.  [Ca2+]i. 
was determined using an InCyt Basic IM™ Fluorescence Imaging System (Intracellular 
Imaging, Inc., Cincinnati, OH) at ambient temperature. The ratio of fluorescence 
intensities measured at 512 nm after excitation at 340 and 380 nm reflected [Ca2+]i.. 
Signals from 18-25 cells were measured in each plate. Cells in which the resting [Ca2+]i. 
was not maintained within 10 nM of the average resting level were excluded from 
analysis, as well as cells that failed to respond to a muscarinic agonist (typically 2-3 
cells/plate). 
Figure 2.1 Shows the resting [Ca2+]i  is lower than 50 nM . After activate mAChR 
by adding Carbamylcholine in the present of calcium, [Ca2+]i  is giving a rise to 500-
700nM and maintain it (Figure 2.1A). When remove extracellular calcium by adding 
EDTA, [Ca2+]i  will decline in a very step slop (Figure 2.1B). 
 
   
 








































Carb. Response in the present of 





Figure 2.2 illustrate [Ca2+]i  can’t keep plateau if Carbamylcholine activate 
mAChR in calcium free buffer [Ca2+]i  (Figure 2.2 A). When adding calcium back to 
buffer, [Ca2+]i  will increase by extracellular calcium influx (Figure 2.2 B). 
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3.1. MUSCARINIC RECEPTOR MEDIATION OF CELLULAR CALCIUM 
RESPONSES 
The resting cytosolic calcium concentration of CHO-M3 cells in BSS typically 
ranged from 33 to 54 nM (Figure 3.1). Stimulation with the muscarinic agonist 
carbamylcholine (10 µM) led to a rapid and sustained increase in cytosolic calcium to a 
concentration that ranged from 500 to 700 nM (Figure 3.1). CHO cells not transfected 
with the M3 receptor gene did not respond to carbamylcholine, and the response to 
carbamylcholine was completely blocked by including 10 µM atropine (a receptor 
antagonist) in the medium. These findings demonstrate that the response is mediated by 
the introduced M3 muscarinic receptor. The threshold concentration for elicitation of a 
response to carbamylcholine was approximately 0.3 µM. 
When calcium was excluded from the extracellular medium, the initial response 
remained intact, but the increase in cytosolic calcium was not maintained (Figure3.1B). 
This is consistent with the common interpretation of these measurements: the initial 
response reflects calcium release from the endoplasmic receptor mediated by the IP3 
receptor, while the sustained plateau phase reflects calcium entry from the extracellular 
medium. The initial phase involves activation of IP3 receptors; the plateau phase reflects 
“capacitive” calcium entry through Orai channels in response to activation by calcium 
sensitive STIM1 proteins in the membrane of the endoplasmic reticulum (Bird et al., 
2008). This interpretation is further supported by the rapid elimination of the plateau 
response upon chelation of extracellular calcium with EDTA (Figure 3.1C). The influx of 
extracellular calcium in response to depletion of calcium in the endoplasmic reticulum 
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has been termed store-activated calcium entry (SOCE). There was a small but significant 
increase in cytosolic calcium concentration when calcium was excluded from the 
extracellular medium (57 ± 14 (N=20) vs. 38  ± 7 nM (N=16); p>0.01). 
Figure 3.1 illustrates the influence of cholinergic activation on cytosolic calcium 
levels in CHO-M3 cells. CHO cells stably transfected with the gene for human M3 
muscarinic acetylcholine receptor (CHO-M3) were loaded with Fura -2AM dye for 40 
min at room temperature. The loading dye was removed and replaced with basal salt 
solution (BSS) and the cells were incubated for an additional 20 min. The BSS solution 
was replaced by fresh BSS or BSS without calcium immediately before measuring 
intracellular calcium levels. Figure 3.1A. Control responses in the presence of 2 mM 
extracellular calcium. Carbamylcholine (10 µM) was added at the time indicated by the 
dashed vertical line. Figure 3.1B. Control responses measured in the absence of 
extracellular calcium. Each line represents the response of an individual cell from a single 
experiment. These results are representative of responses from more than 25 independent 
experiments. The resting calcium level was 38-±7 nM (N=20) in the presence and 57 ± 
14 (N=16) in the absence of extracellular calcium (p< 0.01). Figure 3.1C. Control 
responses in the presence of 2 mM extracellular calcium. Carbamylcholine (10 µM) was 
added at the time indicated by the dashed vertical line then chelating extracellular 
calcium with 20mM of EDTA (N=19). Those components of the calcium response to 
extracellular calcium are evident: a rapid response reflecting release from the 
endoplasmic reticulum and a delayed plateau response dependent on the influx of 
































3.2. INFLUENCE OF ZNO NANOPARTICLES ON CALCIUM RESPONSES 
MEDIATED BY M3 MUSCARINIC RECEPTORS 
Exposure of CHO-M3 cells to ZnO nanoparticles altered cellular calcium 
responses to muscarinic receptor stimulation is several ways (Figure 3.2). Cells that were 
incubated for 1 h with a high (50 µg/ml) concentration of ZnO particles had markedly 
elevated resting calcium concentrations (over 200 nM), although the cells were still able 
to maintain the calcium concentration at this high level (high and variable intracellular 
calcium concentrations are associated with damaged and apoptotic cells). Cells exposed 
to ZnO responded to 10 µM carbamylcholine with an increase in calcium to about 500 
nM, however the increase was not sustained, even though 2 mM extracellular calcium 
was present. The calcium level relaxed to a new, somewhat higher baseline ( ≈250 nM) 
within 2 min. Thus, IP3 receptor mediated release from the endoplasmic reticulum 
appears to be largely intact, while SOCE was selectively blocked.  
A more complete dose-response for the effect of ZnO on resting calcium 
concentration is presented as Figure 2B, which summarizes the results from multiple 
experiments. ZnO increased the resting calcium concentration at all concentrations 
examined (1.5 - 50 µg/ml); there was a 4.8 fold increase with 50 µg/ml ZnO. The cells 
were able to maintain a stable resting calcium concentration at all ZnO concentrations. 
Responses of CHO-M3 cells to carbamylcholine in the presence of lower (2 and 5 
µM) concentrations of ZnO are illustrated in Figure3.3. The signal effect is the failure of 
the cells to maintain a plateau calcium response to muscarinic stimulation.  
Figure 3.2A shows the influence of 50 µg/ ml ZnO nanoparticles on cholinergic 
receptor-mediated changes in cytosolic calcium. Intracellular calcium levels were 
measured in CHO-M3 cells in the absence (Control) and presence of 50 µg/ml ZnO, as 
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indicated. Carbamylcholine was added at the time indicated by the dashed vertical line. 
The cells were incubated with ZnO in media for 1 h. The media was removed and the 
cells were loaded with fura-2AM dye in DMEM for 1 h.  The cells were then rinsed with 
BSS and incubated for a further 30 min before calcium content was measured. ZnO was 
continually present in the treated cells during all of these procedures. Three effects of 
ZnO on the calcium responses were apparent: an increase in resting calcium 
concentration to > 200 nM, a decrease in the phasic initial response and an elimination of 
the plateau response. Figure 3.2B indicates the influence of ZnO nanoparticles on resting 
calcium concentration. Each column and bar represents the mean and standard deviation 
from 3-6 experiments, each including separate measurements from 15-25 cells. The 
resting calcium concentration in the presence of each ZnO concentration was greater than 
the concentration in control cells (p<0.01). 
 
 
Figure 3.2. Influence of 50 µg/ ml ZnO nanoparticles on cholinergic receptor-mediated 




Figure 3.3 illustrates the influence of low concentrations of ZnO nanoparticles on 
M3 muscarinic receptor-mediated changes in cytosolic calcium in cultured CHO-M3 
cells. Responses of CHO-M3 cells to 10 µM carbamylcholine (added at the time 
indicated by the dashed vertical lines) were measured in the absence and presence of 2 or 
5 µg/ml ZnO (Panels A, B and C, as indicated). Cells were pretreated with ZnO for 1 h 
before loading with fura-2AM, and ZnO was continuously present throughout the 
experimental protocol. The lines and vertical bars represent the mean and standard 
deviations from 30-55 cells from 3 independent experiments. Calcium response values at 
four time points are presented in Panel D. “Initial” denotes resting calcium concentration 
before addition of carbamylcholine; “Peak” indicates the initial response measured 10 sec 
after the addition of carbamylcholine and reflecting calcium release from the 
endoplasmic reticulum; “90 min” and “150 min” indicate calcium concentrations 
measured 90 and 150 sec after the addition of carbamylcholine and reflect the ability of 
the cell to maintain the influx of extracellular calcium. *, p<0.05: different from untreated 











Figure 3.3. Influence of low concentrations of ZnO nanoparticles on M3 muscarinic 
receptor-mediated changes in cytosolic calcium in cultured CHO-M3 cells. 
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3.3. CYTOTOXICITY OF ZNO NANOPARTICLES 
CHO-M3 cell viability was revealed by the ability of cells to reduce MTS. ZnO 
induced cytotoxicity in a time and concentration-dependent manner (Figure 3.4). The 
concentration/cytotoxicity curve was remarkably steep following a 24 h exposure to ZnO: 
Toxicity was minimal at concentrations below 20 µg/ml but virtually complete at ZnO 
concentrations above 28 µg/ml. More gradual and less complete toxicity was observed 
with shorter exposure times. It is clear, however, that ZnO has marked effects on resting 
calcium concentrations and SOCE under conditions of concentration and exposure time 
that do not cause significant cytotoxicity. 
Figure 3.4 illustrates cytotoxicity of ZnO. CHO-M3 cells were exposed to ZnO 
nanoparticles at the concentrations indicated on the abscissa for 1, 3 or 24 h, as indicated. 
Cell viability was then determined using the MTS assay. Points and bars indicate the 




Figure 3.4. Cytotoxicity of ZnO. 
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3.4. INFLUENCE OF ZNO NANOPARTICLES ON STORE OPERATED 
CALCIUM ENTRY 
Thapsigargin is a cell permeable, sesquiterpene alkaloid that inhibits the 
sarco/endoplasmic reticulum ATPases (SERCA) that transports calcium from the cytosol 
into the endoplasmic reticulum. Inhibition of SERCAs causes a depletion of calcium 
from the endoplasmic reticulum and a rise in cytosolic calcium (Rogers et al., 1995). 
SOCE can be identified by depleting the endoplasmic reticulum with thapsigargin in a 
calcium-free medium, followed by the reintroducing extracellular calcium (Bird et al., 
2008). Extracellular calcium rapidly enters the cell through SOCE channels previously 
opened in response to thapsigargin-mediated depletion of endoplasmic reticulum calcium 
stores.  
In CHO-M3 cells incubated in BSS containing 2 mM calcium, thapsigargin 
elicited a two-phase response, an initial rather slow release followed by a sustained 
calcium plateau (Figure 3.5). The plateau phase was immediately eliminated by addition 
of 5 mM EDTA to the extracellular medium, indicating its dependence on the influx of 
extracellular calcium. Exposure of CHO-M3 cells to thapsigargin (1 µM) in a calcium-
free medium led to an increase of intracellular calcium to about 260 nM (Figure 3.5). 
Calcium concentration peaked 75 sec after thapsigargin addition and returned to baseline 
within a few minutes. Addition of carbamylcholine after return to the baseline failed to 
elicit any response (not shown).  
Figure 3.5 illustrates the influence of thapsigargin on cytosolic calcium 
concentrations in CHO-M3 cells. Thapsigargin (1 µM) was added at the time indicated 
by the vertical dashed line. Calcium concentration was determined in the absence and 
presence of extracellular calcium, as indicated. Each line is the average response from 23 
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Addition of 2 mM calcium following exposure of CHO-M3 cells to thapsigargin 
(1 µM) in a calcium-free medium resulted in a rapid and persistent increase in calcium 
concentration to ≈ 600 nM (Figure 3.6A). The influences of ZnO nanoparticles on SOCE 
measured in CHO-M3 in this manner (i.e., in calcium-free media) are illustrated in Figure 
3.6B and 6C. Exposure to 1.5, 5 or 10 µg/ml ZnO produced the previously described 
concentration-dependent rise in resting cytosolic calcium concentration. Thapsigargin 
produced a small, slowly developing and transient increase in cellular calcium 
concentration; there was no difference in the maximum calcium concentration attained in 
response to thapsigargin in the presence of ZnO (1.5 -10 µg/ml), although the magnitude 
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of the calcium response differed because of the higher baseline concentration. However, 
ZnO greatly attenuated the subsequent rise in calcium concentration in response to the 
addition of extracellular calcium: There was no response in the presence of 10 µg/ml 
ZnO, and responses were smaller and of shorter duration in cells exposed to 1.5 and 5 
µg/ml ZnO (Figure 3.6B and 3.6C).  
Figure 3.6 shows the influence of ZnO on store operated calcium entry 
experimentally isolated by exposure to thapsigargin in the absence of extracellular 
calcium, followed by the reintroduction of calcium. Panel A: CHO-M3 cells incubated in 
the BSS not containing calcium were exposed to thapsigargin (1 µM) at the time 
indicated by the first dashed vertical line. Calcium was added to the external medium at 
the time indicated by the second dashed vertical line to a final concentration of 2 mM. 
The increase in cytosolic calcium concentration caused by the reintroduction of calcium 
in ER calcium-depleted cells reflects the capacitive store operated calcium entry (SOCE) 
(Bird et al., 2008). Panel B: CHO-M3 cell were incubated in the absence or presence of 
1.5, 5 or 10 µg/ml ZnO nanoparticles for 1.5 h before being loaded with fura-2AM for 
calcium measurements. Thapsigargin (1µM) and calcium (2 mM) were added 
sequentially at the times indicated by the dashed vertical lines. Each line represents the 
mean from 15-24 cells from a typical experiment; three identical experiments yielded 
essentially similar results. Panel C: Summary of ZnO influences on store operated 
calcium entry. Each bar represents the mean and standard deviation from 3 experiments 
performed as indicated in Panel B. Cells were untreated (Control) or exposed to 1.5, 5 or 
10 µg/ml ZnO, as indicated, for 1.5 h before being loaded with fura-2Am for 
measurement of intracellular calcium. The 3 columns indicate the calcium concentrations 
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before (“Initial”) addition of thapsigargin, at the maximum response realized within 100 
sec of the addition of thapsigargin (“Thapsigargin Peak”), or the maximum response 
achieved within 100 sec of raising the extracellular calcium concentration to 2 mM 
(“Calcium Readdition Peak”). Resting calcium concentrations in the presence of all ZnO 
concentrations were different from the control level (p<0.01). ZnO did not affect the 
“Thapsigargin Peak” calcium concentrations; the “Calcium Readdition Peak” 




Figure 3.6. Influence of ZnO on store operated calcium entry experimentally isolated by 
exposure to thapsigargin in the absence of extracellular calcium, followed by the 









Figure 3.6. Influence of ZnO on store operated calcium entry experimentally isolated by 
exposure to thapsigargin in the absence of extracellular calcium, followed by the 
reintroduction of calcium. 
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3.5. INFLUENCE OF ZNO NANOPARTICLES ON MUSCARINIC RECEPTOR 
LIGAND BINDING PROPERTIES 
The possibility that ZnO affected the muscarinic receptor component of this 
signal transduction pathway was evaluated using a specific radiolabelled probe, [3H]MS. 
[3H]MS binding was well-described by a binding isotherm for ligand binding to a single 
population of independent receptors (Figure 3.7A; Table 3.1). Receptor affinity for 
[3H]MS was high; nonlinear regression analysis revealed a dissociation constant of 1.9 ± 
0.2 nM. Binding affinity was not affected by the inclusion of high concentrations of ZnO 
nanoparticles (10 and 20 µg/ml) in the binding reaction (Table 3.1). [3H]MS binding was 
also measured in membranes from CHO-M3 that had been exposed to ZnO nanoparticles 
(10 and 20 µg/ml) for 5 h before the cells were harvested for binding measurements. 
Again, there was no effect on [3H]MS binding affinity (Table 3.1). There was, however, a 
consistent increase in the concentration of binding sites, expressed as binding sites/total 
cell protein. A time course for the development of this increase is presented in Figure 
3.7B. The concentration of sites increased following incubations with 2 µg/ml ZnO for up 
to 8 h, but decreased with longer exposure times.  
Agonist binding to muscarinic receptors reveals certain aspects of receptor 
organization. Agonist binding was inferred from the ability of carbamylcholine to inhibit 
the binding of 0.3 M [3H]MS to the receptor (Figure 8A). Carbamylcholine inhibited 
[3H]MS binding with a uniformly low affinity (IC50 ≈ 40 µM); the shape of the isotherm 
was consistent with binding to a single population of receptors. Inclusion of 
5’guanylylimidodiphosphate (Gpp(NH)p; 50 µM) in the incubation medium had a small 
affect on the ability of carbamylcholine to inhibit [3H]MS binding. ZnO (2 µg/ml) 
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markedly increased carbamylcholine binding affinity, although Gpp(NH)p did not affect 
carbamylcholine binding in the presence of ZnO (Figure 3.8A).  
Muscarinic receptors can also be regulated by ligands that bind to an allosteric 
site. This allosteric effect is clearly evident in a decrease in the rate of [3H]MS 
dissociation in the presence of the allosteric ligand (e.g., (Stahl and Ellis, 2010)). We 
measured this dissociation in the presence of a high (20 µg/ml) concentration of ZnO 
(Figure 8B). ZnO had no effect on atropine-induced dissociation of an M3-[3H]MS 
complex in CHO-M3 cells. Moreover, ZnO did not affect the ability of the allosteric 
ligand gallamine to slow the rate of dissociation (Figure 3.8B; Table 1). 
Figure 3.7 shows the influence of ZnO nanoparticles on antagonist binding to 
muscarinic receptors in CHO-M3 cells. Panel A. The specific binding of [3H]N-
methylscopolamine ([3H]MS) was measured at the concentrations indicated on the 
abscissa. The curve is drawn according to parameters derived from a nonlinear fit of the 
data to a model for ligand binding to a single population of independent receptors. Each 
data point reflects the mean from 3 experiments performed in triplicate. Binding 
parameters and experimental variation are presented in Table 3.1. An increase in the 
receptor concentration was a consistent observation. This increase was a function of time 
of exposure to ZnO, as shown for 2 µg/ml ZnO in Panel B. Each bar represents the 
receptor concentration in CHO-M3 cells determined by nonlinear regression on data from 






Figure 3.7. Influence of ZnO nanoparticles on antagonist binding to muscarinic receptors 




Figure 3.8 illustrate the influence of ZnO nanoparticles on agonist binding to M3 
muscarinic receptors expressed by CHO cells. Panel A. The ability of carbamylcholine to 
inhibit the specific binding of 0.3 nM [3H]MS was determined in triplicate in the absence 
(circles) or presence (squares) of 2 µg/ml ZnO in the absence (open symbols) or presence 
(closed symbols) of 10 µM Gpp(NH)p. Each point is the average of 3 measurements from 
3 independent experiments. Carbamylcholine inhibition of [3H]MS binding was mitigated 
in the presence of 5’-Gpp(NH)p (IC50’s = 48 ± 6 and 100 ± 19 in the absence and 
presence of 5’-Gpp(NH)p, respectively; p<0.01). Carbamylcholine inhibition of [3H]MS 
binding was greatly enhanced in the presence of ZnO (IC50 = 4.5 ± 0.4; p<0.01), but this 
inhibition was no longer sensitive to 5’-Gpp(NH)p (IC50 = 4.5 ± 0.3). Panel B. The 
influence of ZnO nanoparticles on allosteric regulation of M3 muscarinic receptors 
expressed in CHO cells is illustrated. The dissociation of [3H]MS was measured by 
incubating CHO-M3 cell membranes with 1 nM [3H]MS for 1 hour before adding an 
excess of atropine (10 µM) to block the forward reaction. The off rate was measured in 
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the absence (circles) and presence (squares) of 10 µM gallamine in the absence (open 
symbols) and presence (closed symbols) of 10 µg/ml ZnO. Dissociation rate constants are 




Figure 3.8. Influence of ZnO nanoparticles on agonist binding to M3 muscarinic 














Table 3.1. Parameters associated with [3H]MS binding to M3 receptors expressed in 
CHO cells. 
 





k-1 k-1, gallamine 
Control 0.192 ± 0.2 2.65 ± 0.3 0.021 ± 0.005 0.006 ± 0.002 
ZnO 10 µg/ml,  0.167 ± 0.3 3.03 ± 0.2   
ZnO 10 µg/ml, 
5 h 
0.198 ± 0.4 2.93 ± 0.4 0.024 ± 0.008 0.007 ± 0.002 
ZnO 20 µg/ml,  0.183 ± 0.4 3.03 ± 0.3   
ZnO 20 µg/ml, 
5 h 
0.160 ± 0.3 2.82 ± 0.4   
 
[3H]MS binding was measured in untreated cells (Control) or in cells exposed to ZnO 
acutely or for 5 hours before harvesting the cells for binding measurements, as indicated. 
KD, dissociation constant; [Receptor], receptor density. 
k-1, rate constant of dissociation, sec-1, measured in the absence and presence of 10 µM 
gallamine, as indicated. Gallamine decreased the dissociation rate constants (p < 0.01).; 
the rate constants were not altered in the presence of 10 µgm/ml ZnO.  
Mean ± S.D. (N = 3). None of the parameters measured in the presence of ZnO were 




The goal of this research was to determine the effects of ZnO nanoparticles on 
muscarinic signaling. CHO cells are widely used in the study of muscarinic pathways. 
CHO cells do not natively express muscarinic receptors or acetylcholinesterase, but 
express elements of phospholipase Cβ and adenylate cyclase signaling pathways. 
Moreover, CHO cells transfected with transgenes for the different muscarinic receptor 
subtypes respond to muscarinic agonists in pharmacologically and physiologically 
appropriate fashions.  
A wide variety of metal oxide nanoparticles are toxic to cultured cells, producing 
oxidative stress that induces apoptosis (Huang et al., 2009). In the present study, ZnO 
nanoparticles induced cytotoxicity in CHO cells in a concentration and time dependent 
fashion. However, inhibitory effects of nanoparticles on muscarinic signaling and SOCE 
could be detected under conditions that did not produce overt cytotoxicity. 
The present results demonstrate some specific effects of ZnO particles on early 
aspects of M3 receptor activation. Receptor binding of the antagonist [3H]MS was not 
affected, nor were allosteric ligand effects on receptor binding. Interestingly, ZnO 
nanoparticles markedly enhanced the ability of carbamylcholine to inhibit [3H]MS 
binding, and this increase was not affected by inclusion of a guanine nucleotide in the 
incubation medium. Such effects have been previously associated with metals and protein 
oxidants (Aronstam et al., 1978; Aronstam and Eldefrawi, 1979). The functional 
significance of this shift is unclear, however, since downstream signaling (e.g., IP3 
receptor-mediated calcium release from the ER) remained intact. It should be noted, 
however, that ligand binding to M3 receptors expressed in model systems is much less 
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sensitive to both guanine nucleotides and allosteric agents than either M2 or M4 
muscarinic receptors. A determination of the effects of ZnO on these receptor subtypes is 
presently underway.  
ZnO had a paradoxical positive effect on the concentration of M3 binding sites. 
The reasons for this effect are uncertain. It is possible that the cytotoxic effects of ZnO 
particles preferentially affect the expression of cellular proteins with high turn over rates, 
thereby increasing M3 concentration expressed on the basis of cellular protein 
(muscarinic receptors, and many membrane proteins, have relatively long half lives (e.g., 
(Haddad et al., 1995)). An alternate explanation is that oxidative stress increased 
expression controlled by the cytomegalovirus promoter that is upstream of the M3 coding 
region (Bruening et al., 1998).  
ZnO particles had two prominent effects on the IP3 signaling pathway activated 
by M3 activation: an increase in resting calcium concentration and a potent inhibition of 
the SOCE. ZnO increased resting [Ca2+]i from 40 to 130 nM when present in 
noncytotoxic concentrations from 1.5 to 10 µg/ml.  The cells were capable of maintaining 
[Ca2+]i at the new, higher [Ca2+]i for at least an hour. The basis for this increase is not 
clear, but may involve impairment of the active transport processes or ion exchange 
mechanisms that determine calcium concentration. 
ZnO particles did not affect calcium release from the ER caused by thapsigargin 
inhibition of the Ca2+-ATPases that transport calcium from the cytosol to the lumen of the 
ER. The maximal cytosolic calcium concentrations produced by exposure to thapsigargin 
were not affected by ZnO particles, however, since the resting [Ca2+]i was higher in the 
presence of ZnO, the absolute magnitude of the response was lower. After a few minutes, 
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the cells reverted to the resting [Ca2+]I associated with that particular concentration of 
ZnO, i.e., homeostatic mechanisms maintained [Ca2+]at at the new baseline level. This 
suggests that the rise in resting [Ca2+]I in the presence of ZnO does not involve a change 
in Ca2+-ATPases that are susceptible to thapsigargin (i.e., SERCAs).  
The most prominent effect of ZnO particle on the muscarinic receptor – IP3 
signaling pathway was a selective inhibition of the store-operated calcium entry (SOCE) 
that is activated by the depletion of calcium from the endoplasmic reticulum. The 
molecular details of this classic pathway have recently been described in detail (e.g., 
(Putney, 2009). This effect is manifested as a decrease in the plateau phase of the 
response that is dependent on the entry of extracellular calcium (Figure 3), as well as in a 
calcium readdition paradigm in which endoplasmic reticulum stores of calcium are first 
depleted by treatment with thapsigargin in cells incubated in a calcium-free medium. 
SOCE entry can then be monitored by adding calcium to the extracellular medium. The 
concentration dependence for both effects is the same (EC50 ≈ 2 µg/ml).  
ZnO particles had a small effect on the initial rise in [Ca2+]I to carbamylcholine 
that reflects calcium release from the endoplasmic reticulum through activated IP3 
receptor Ca2+ channels. For example, the initial peak was reduced 20% by a ZnO 
concentration (5 µg/ml) that totally eliminated SOCE within 60 sec. At even the highest 
ZnO concentrations tested (50 µg/ml), IP3 receptor-mediated calcium release was not 
decreased by more than 30%. The contribution of the increased resting [Ca2+]I on the 
decrease in magnitude of the IP3 receptor-mediated calcium release is not clear. 
The aspect of the ZnO nanoparticles responsible for these effects is unclear, and 
studies are underway utilizing particles of different size and surface area. Zinc metal ions 
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have multiple and profound effects on ion channel functions (and muscarinic receptors, 
e.g.,  (Aronstam et al., 1978)), however, ICP-MS analysis revealed little dissolution of 
zinc from the particles under the present experimental conditions (Huang et al., 
unpublished observations). The extent to which the ZnO effects can be ascribed to 
oxidative stress is similarly uncertain, and will be the subject of further study. 
Thus, the present results demonstrate a specific inhibitory effect of ZnO 
nanoparticles on the M3 muscarinic – phospholipase Cβ signaling pathway: ZnO 
particles selectively inhibit store operated calcium entry. ZnO particles also change the 
resting [Ca2+]i without compromising the homeostatic mechanisms that maintain 
cytosolic calcium concentrations at low levels. The effects of ZnO particles on this 
pathway are specific insofar as receptor antagonist binding, allosteric muscarinic receptor 
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